Marvel Biosciences (TSXV:MRVL) Accumulated other comprehensive income (loss) : C$0.33 Mil (As of Jan. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Marvel Biosciences Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Marvel Biosciences's Accumulated other comprehensive income (loss) for the quarter that ended in Jan. 2025 was C$0.33 Mil.

Marvel Biosciences's quarterly Accumulated other comprehensive income (loss) increased from Jul. 2024 (C$0.00 Mil) to Oct. 2024 (C$0.32 Mil) and increased from Oct. 2024 (C$0.32 Mil) to Jan. 2025 (C$0.33 Mil).

Marvel Biosciences Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Marvel Biosciences's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences Accumulated other comprehensive income (loss) Chart

Marvel Biosciences Annual Data

Trend

Jul20

Jul21

Jul22

Jul23

Jul24

Accumulated other comprehensive income (loss)

Marvel Biosciences Quarterly Data
	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24	Jan25
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial														-	-	-	0.32	0.33

Marvel Biosciences Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Marvel Biosciences Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Marvel Biosciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (TSXV:MRVL) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

MBCOF:USA

Address

505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2

Website

https://www.marvelbiotechnology.com

Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.

Executives